Beyond the API: Mapping the Secondary Patent Thicket to Forecast Generic Entry
In the high-stakes world of pharmaceutical innovation, the path from groundbreaking drug discovery to widespread patient access is fraught with complexities—many of which are hidden beneath the surface. While headlines often focus on patent expirations…
Beyond the API: Mapping the Secondary Patent Thicket to Forecast Generic Entry Read Post »
